What We Do / Events / WMA DoH Conference Tokyo

WMA DoH Conference Tokyo

Start Date: February 28, 2013
End Date: March 1, 2013
Location: Imperial Hotel Tokyo, Tokyo, Japan

Expert Conference on the Revision of the Declaration of Helsinki – Tokyo, 28 February-1 March 2013

28 February – 1 March 2013
Imperial Hotel Tokyo, Tokyo, Japan

Agenda (final)

To download the presentations please click on the speakers’ names:

Day 1 Thursday, 28 February 2013
2:00 Welcome address
Yoshitake Yokokura, President of the Japan Medical Association (JMA)
Fumimaro Takaku, President of the Japanese Association of Medical Sciences
Cecil Wilson, President of the World Medical Association (WMA)
2:15 Welcome remarks
Norihisa Tamura, Minister, Ministry of Health, Labor and Welfare, Japan
2:20 Opening remarks
Ramin Parsa-Parsi, Chair of the WMA DoH Workgroup
2:30-3:45 Keynote speeches
Chair: Ramin Parsa-Parsi, Chair of WMA DoH Workgroup

Keynote speech 1
Urban Wiesing, University of Tuebingen, Germany

Keynote speech 2
Heather Widdows, University of Birmingham, UK
4:15-5:30 Session 1: Biobanks
Chair: Masami Ishii, Vice-Chairman of Council of the WMA & WMA DoH Workgroup
Chair: Miguel R. Jorge, Brazilian Medical Association & WMA DoH Workgroup

Ryuichi Ida, Doshisha University, Japan
Alastair Campbell, Centre for Biomedical Ethics, National University of Singapore,Singapore
Day 2 Friday, 1 March 2013
9:00-10:15 Session 2: Insurance/compensation/protection
Chair: Wonchat Subhachaturas, Past President of the WMA
Chair: Torunn Janbu, Chairperson of WMA Medical Ethics Committee & WMA DoH Workgroup member

Tatsuo Kuroyanagi, Legal Advisor of the JMA, Japan
Daniel Fu-Chang Tsai, Department of Social Medicine, National Taiwan University College of Medicine, Taiwan
Elmar Doppelfeld, Council of Europe
10:35-11:50 Session 3: Resource poor settings / Post-study arrangements
Chair: Dong Chun Shin, Chairman of Council of the CMAAO
Chair: Poul Jaszczak, Danish Medical Association & WMA DoH Workgroup
Somkiat Wattanasirichaigoon, Scientific Session of the Medical Association of Thailand & Faculty of Medicine, Srinakarinthwirot University, Thailand
Prijo Sidipratomo, Indonesian Medical Association Medical Ethics Committee, Indonesia
Jose Asa Sabili, Philippine Medical Association, Philippines
1:20-2:20 Session 4: Vulnerable groups
Chair: Ming-Been Lee, President of the CMAAO, Taiwan
Chair: Mukesh Haikerwal, Chairman of Council of the WMA
Bomoon Choi, College of Medicine, Catholic University of Korea, & Korean Society for Medical Ethics, Republic of Korea
Ajay Kumar, Indian Medical Association, India
2:20-3:10 Session 5: Ethics Committees
Chair: Margaret Mungherera, Uganda Medical Association & President-Elect, World Medical Association
Chair: Peter Carmel, American Medical Association & WMA DoH Workgroup
Kaori Muto, Department of Public Policy, Institute of Medical Science, University of Tokyo, Japan
3:30-4:15 Session 6: General Comments
James McCormick, U.S. Embassy Tokyo, on behalf of the U.S. Department of Health and Human Services (HHS)
Yasuyuki Sahara, Research and Development Division, Ministry Health, Labor and Welfare (MHLW)
Isao Teshirogi, Japan Pharmaceutical Manufacturers Association (JPMA)
Salvatore Alesci, Scientific Affairs, Pharmaceutical Research and Manufacturers of America (PhRMA)
4:15-5:15 Consensus building / summing up
Round table discussion
Facilitator: Jeff Blackmer, Canadian Medical Association & WMA DoH Workgroup
Facilitator: Peter Carmel, American Medical Association & WMA DoH WorkgroupClosing & next steps
Otmar Kloiber, Secretary General of the WMA
Tai Joon Moon, President Emeritus of the KMA, former President of the WMA
Takashi Hanyuda, Vice-president of the JMA